BioSpace News Archive

Arteco Specialty Services is proud to introduce FDA and EPA approved and Organic Materials Review Institute (OMRI) listed Disinfect & Shield™, answering the urgent need for a safe and effective disinfectant that kills SARS-CoV-2, the virus that causes COVID-19 – plus other dangerous viruses, bacteria and microbes – on contact

Athersys, Inc. (NASDAQ: ATHX) (Athersys) announced today that it intends to offer for sale $50 million of shares of its common stock, par value $0.001 per share (Common Stock), in an underwritten public offering. In addition, Athersys expects to grant the underwriters a 30-day option to purchase additional shares of Common Stock in an amount of up to 15% of the number of shares of Common Stock offered in the public offering.

Recent technological advancements and adoption of new implant materials for various indications, fractures, and support injuries have transformed the ankle syndesmosis treatment devices market. Use of titanium and biodegradable implants for fracture fixation has increased due to rise in awareness about the advantages of these implant materials among surgeons.

Inadequacy of vaccines to combat increasing rare infectious diseases in livestock and companion animals is the key driving factor aiding the growth of the autogenous vaccines market. Autogenous vaccines are an efficient alternative to antibiotics that control and prevent infectious diseases.

Thousands of donations -- from masks, scrubs and sneakers, to snacks and water -- have poured in from around the Commonwealth and country to help protect and support nurses and healthcare professionals

Global demand for dural graft is expected to grow significantly, owing to rising burden of neurosurgical diseases leading to increasing cranial and spinal duraplasty, and rapid technological advancements in dural graft products.

Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced that the United States (U.S.) Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to TransCon hGH ( lonapegsomatropin ), as a treatment for growth hormone deficiency (GHD). TransCon hGH is an investigational long-acting prodrug of somatropin (human gro

T2 Biosystems, Inc. a leader in the rapid detection of sepsis-causing pathogens, announced that it issued inducement awards to four new employees.

According to a new study published by Persistence Market Research (PMR), the global human platelet lysate market is estimated to be valued at US$ 45.8 Mn in 2018 and is expected to expand at a CAGR of 3.6% over 2018–2026, to reach US$ 61.0 Mn by 2026 end.

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) and BioCheck, Inc., a privately-held San Francisco -based company focused on in vitro diagnostics, today announced that they have entered into a commercial supply and collaboration agreement. Under the agreement, Accelerate Diagnostics will distribute the BioCheck MS-FAST, a fully-automat